PALOBIOFARMA SL has a total of 83 patent applications. It increased the IP activity by 600.0%. Its first patent ever was published in 2006. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are CHONG JAYHONG A, INVEST Y NUTRICION S L and TAKEDA PHARMACEUTICAL COMPANY LIMITED.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | EPO (European Patent Office) | 7 | |
#3 | Australia | 6 | |
#4 | Brazil | 6 | |
#5 | Canada | 6 | |
#6 | China | 6 | |
#7 | Spain | 6 | |
#8 | Republic of Korea | 6 | |
#9 | Mexico | 6 | |
#10 | EAPO (Eurasian Patent Organization) | 5 | |
#11 | Serbia | 5 | |
#12 | United States | 5 | |
#13 | Hungary | 3 | |
#14 | Montenegro | 3 | |
#15 | South Africa | 3 | |
#16 | Philippines | 1 | |
#17 | Slovenia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Castro Palomino Laria Julio | 26 |
#2 | Camacho Gomez Juan Alberto | 24 |
#3 | Camacho Gomez Juan | 19 |
#4 | Camacho Gómez Juan | 18 |
#5 | Castro-Palomino Laria Julio Cesar | 14 |
#6 | Mendoza Lizaldez Adela | 11 |
#7 | Gonzalez Lio Lyhen | 9 |
#8 | El Maatougui Abdelaziz | 9 |
#9 | Camacho Gómez Juan Alberto | 8 |
#10 | Juan Camacho Gómez | 7 |
Publication | Filing date | Title |
---|---|---|
EP3592734A1 | Amine salt of (1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcarbamoyl)cyclopentane carboxylic acid | |
ES2676535A1 | MODULATORS OF A3 ADENOSINE RECEIVERS | |
ES2580702A1 | 2-Aminopyridine derivatives as adenosine A2b receptor antagonists and MT3 melatonin receptor ligands | |
ES2578363A1 | A3 adenosine receptor modulators | |
ES2480341A1 | New derivatives of pyrimidine as phosphodiesterase 10 (PDE-10) inhibitors | |
ES2365960A1 | NEW ANTAGONISTS OF ADENOSINE RECEPTORS. | |
ES2331220A1 | NEW COMPOUNDS AS ANTAGONISTS OF ADENOSINE A1 RECEPTORS. | |
WO2007116106A1 | Novel compounds as antagonists of adenosine a1 receptors |